Oriol Iborra Egea
Has grant
Chief Executive Officer
SpainResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Oriol Iborra Egea is the Chief Executive Officer at NIMBLE Diagnostics, S.L, located in Spain. His research areas focus on myocardial health, particularly the role of immunotherapy and artificial intelligence in treating cardiovascular diseases. Recent publications include studies on CAR immunotherapy targeting myocardial fibrosis and the impact of iPSC therapy in myocardial infarction models. His work also explores biomarkers in cardiogenic shock and the molecular mechanisms in heart failure.
Recent Grants
Grant: Close
In vitro method for predicting mortality in patients suffering from cardiogenic shock
Open Date: 2023-01-01
Close Date: 2024-01-01
Grant: Close
Young innovator Award 2021
Open Date: 2022-11-01
Close Date: 2024-11-01
Grant: Close
In vitro method for predicting mortality in patients suffering from cardiogenic shock
Open Date: 2022-11-01
Close Date: 2024-05-01
Grant: Close
Somatic mutations and clonal hematopoiesis as risk factors in atherosclerosis: from the laboratory to the clinic (AtheroClonal)
Open Date: 2022-06-01
Close Date: 2025-06-01
Grant: Close
In vitro method for predicting mortality in patients suffering from cardiogenic shock
Open Date: 2021-09-01
Close Date: 2023-03-01
Articles (9)
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (4)
Santiago Roura
Associate Professor
Universitat de Vic - Universitat Central de Catalunya
Joshua Wythe
Associate Professor
University of Virginia School of Medicine
Cristina Segú-Vergés
Chief Compliance Officer and Head of Medical Writing Department
Anaxomics (Spain)
Cameron McAlpine
Associate Professor
Icahn School of Medicine at Mount Sinai
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.